Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT01840293

Breast Cancer Proteomics and Molecular Heterogeneity

Sponsor: Cancer Trials Ireland

View on ClinicalTrials.gov

Summary

Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 protein and the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) genes Secondary objective: * To expand our understanding of the complex molecular pathways dictating the progression of breast cancer and their response to different treatment regimes. * To relate proteomic findings to survival data * To identify potential serum markers of breast cancer progression

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1780

Start Date

2013-02

Completion Date

2038-01

Last Updated

2025-12-19

Healthy Volunteers

No

Locations (6)

Cork University Hospital

Cork, Ireland

Beaumont Hospital

Dublin, Ireland

St James's Hospital

Dublin, Ireland

St. Vincent's University Hospital

Dublin, Ireland

University Hospital Limerick

Limerick, Ireland

University Hospital Waterford

Waterford, Ireland